SynthesisPloS one2020

Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review.

Rashidul Alam Mahumud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.